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To the Editor: Human granu-
locytic anaplasmosis (HGA) is an 
emerging tick-borne infectious dis-
ease caused by Anaplasma phagocy-
tophilum, an obligatory intracellular 
bacterium (1). Recently, 2 cases of 
HGA were identified by a retrospec-
tive study in Japan (2). For serodiag-
nosis of HGA, A. phagocytophilum 
propagated in HL60 cells is usually 
used as an antigen, especially by in-
direct immunofluorescent assay (IFA) 
(3). However, the serum from these 2 
patients in Japan reacted with antigens 
of A. phagocytophilum cultured in 
THP-1 cells rather than in HL60 cells 
in IFA (2). In A. phagocytophilum, a 
p44/msp2 multigene family encoding 
multiple 44-kDa immunodominant 
major outer membrane protein species 
(so-called P44) exists on the genome, 
and these multigenes are similar, but 
not identical, to each other, and the 
bacterium generates antigenic varia-
tions because of gene conversion (4). 
The previous studies showed that A. 
phagocytophilum expresses predomi-
nantly 2 species of p44/msp2 tran-
scripts in THP-1 cells, but it produces 
the variation of P44 protein species in 
HL60 cells (2,5). This finding strongly 
suggested that A. phagocytophilum 
grown in THP-1 cells differs serologi-
cally from that in HL60 cells. Our se-
rologic analysis found 4 recent cases 
of HGA in Japan by using infected 
THP-1 and HL60 cells as antigens, 
and some P44 immunoreactive pro-
tein species of A. phagocytophilum 
that were associated with the respec-
tive cell line cultures, binding to anti-
bodies from the 4 patients’ serum, also 
were identified.
In 2010 and 2011, nine patients in 
Shizuoka Prefecture, Japan, who had 
rickettsiosis-like symptoms, were sus-
pected to have Japanese spotted fever 
or scrub typhus, but they were sero-
logically negative by IFA. Therefore, 
IFA for HGA was conducted. In 4 of 
the patients, antibodies to A. phago-
cytophilum were detected in serum 
by using A. phagocytophilum cultured 
in THP-1 and HL60 cells as antigens 
(Table). In IFA tests for HGA, IgM 
and/or IgG from the patients’ serum 
samples reacted with A. phagocyto-
philum cultured in THP-1, HL60, or 
both, and the seroconversions were 
observed in convalescent-phase serum 
from all patients. The clinical manifes-
tation and laboratory findings for the 4 
patients are summarized in the online 
Technical Appendix Table, (wwwnc.
cdc.gov/EID/article/20/3/13-1337-
Techapp1.pdf). Western blot analysis 
further confirmed the specific reaction 
to P44 protein antigens (P44s) of A. 
phagocytophilum cultured in THP-1 
and HL60 and to recombinant P44–1 
protein (rP44–1) in the serum samples 
(online Technical Appendix Figures 1 
and 2), supporting the IFA results in 
the Table.
To identify P44 immunodominant 
protein species binding to antibod-
ies from the patients’ serum, we se-
lected P44–47E and P44–60 proteins 
that are dominantly expressed by A. 
phagocytophilum propagated in THP-
1 cells (2) and P44–18ES protein that 
frequently predominates by A. phago-
cytophilum cultured in HL60 cells (6) 
as representatives for the preparation 
of recombinant proteins. The central 
hypervariable regions of the respec-
tive P44 proteins (online Technical 
Appendix Figure 3) were produced 
as recombinant proteins in vitro by 
insect cell–free protein synthesis 
system (Transdirect Insect Cell Kit; 
Shimadzu Co., Kyoto, Japan) (7) to 
avoid the strong nonspecific reaction 
with human serum that occurs in the 
Escherichia coli expression system. 
In Western blot analyses using these 
3 recombinant P44 proteins (rP44–60 
and rP44–47E for THP-1 and rP44–
18ES for HL60) as antigens, most of 
the serum from the patients was reac-
tive with A. phagocytophilum cultured 
in THP-1 cells in IFA bound to either 









 A. phagocytophilum propagated	in	HL60	cells	
(rP44	species) 
IgM IgG  IgM IgG 
1 1 80	(r60) <20  80	(r18ES) <20 
 15 160	(r60) <20  160	(r18ES) <20 
 30 320	(r60) 20	(r60)  320	(r18ES) <20 
2 13 40 40	(r47E)  <20 20 
3 3 40 80	(r60)  <20 20	(r18ES) 
 7 40 80	(r60)  <20 20	(r18ES) 
 24 80	(r60) 160	(r60)  <20 40	(r18ES) 
4 4 160	(r47E) 40  <20 <20 








patients’ serum reactive with A. phago-
cytophilum cultured in HL60 cells in 
IFA bound to rP44–18ES (online Tech-
nical Appendix Figure 4; Table). This 
finding strongly supports the results of 
IFA and Western blot analyses with the 
infected THP-1 and HL60 cells.
In Japan, rickettsioses such as Jap-
anese spotted fever and scrub typhus, 
caused by Rickettsia japonica and 
Orientia tsutsugamushi, respectively, 
occur frequently. However, fever of 
unknown cause and rickettsiosis-like 
symptoms still occur in some patients. 
Detection of A. phagocytophilum in 
ticks was first reported in 2005 in cen-
tral Japan (8). Since then, DNA of A. 
phagocytophilum has been detected in 
ticks inhabiting several places of Japan 
(9,10). However, little was known about 
human infection with A. phagocytophi-
lum for many years, probably because 
of the poor selection of the culture cell 
line used as infected cell antigens for 
serodiagnosis. Our previous study first 
documented HGA in Japan and recom-
mended that A. phagocytophilum prop-
agated in THP-1 and in HL60 cells be 
used as antigens to avoid misdiagnos-
ing cases of HGA. Our current study 
demonstrates the presence of specific 
antibodies against the central hyper-
variable regions of P44–47E, P44–60, 
or P44–18ES proteins that predominate 
in infected THP-1 or HL60 cells, prob-
ably being suitable as protein antigens 
for serodiagnosis of HGA. The rP44–1 
protein whose recombinant plasmid 
had previously been constructed for E. 
coli expression system may be avail-
able as well. Thus, our study provides 
substantial information about the use-
fulness of suitable P44 immunoreactive 
protein species of A. phagocytophilum 
as antigens for serodiagnosis of HGA.
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